NCT00344461View on ClinicalTrials.gov

A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine

PHASE4CompletedINTERVENTIONAL

Enrollment

54

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

HIV

Interventions

DRUG

Nevirapine, FTC, and Tenofovir

One arm only - Open label using FTC 200 mg p.o. qd, and Tenofovir 300 mg p.o. qd, and Nevirapine 200 mg b.i.d.

Trial Locations (1)

21201

University of Maryland, Institute of Human Virology, Baltimore

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

University of Maryland, Baltimore

OTHER